NVO - Novo Nordisk A/S

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in DKK. All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue18,014,00015,856,00015,710,000
Cost of Revenue2,844,0002,437,0002,356,000
Gross Profit15,171,00013,419,00013,354,000
Operating Expenses
Research Development2,260,0002,066,0001,981,000
Selling General and Administrative5,013,0004,482,0004,176,000
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss7,897,0006,870,0007,197,000
Income from Continuing Operations
Total Other Income/Expenses Net201,00013,00012,000
Earnings Before Interest and Taxes8,098,0006,883,0007,210,000
Interest Expense247,000103,000880,000
Income Before Tax7,851,0006,780,0006,330,000
Income Tax Expense1,702,0001,401,0001,255,000
Minority Interest---
Net Income From Continuing Ops6,150,0005,380,0005,074,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income6,150,0005,380,0005,074,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares6,150,0005,380,0005,074,000